nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advancing patient-centered metrics for heart transplantation: The role of days alive and outside the hospital
|
Pegues, J'undra N. |
|
|
44 |
3 |
p. 389-400 |
artikel |
2 |
A systematic review of reporting and handling of missing data in observational studies using the UNOS database
|
Baker, William L. |
|
|
44 |
3 |
p. 462-468 |
artikel |
3 |
Cancer as an independent mortality risk in chronic thromboembolic pulmonary hypertension
|
Nakamura, Junichi |
|
|
44 |
3 |
p. 339-348 |
artikel |
4 |
Chronic Thromboembolic Pulmonary Hypertension and Cancer: a true relationship, but one likely beyond coagulation
|
Gerges, Christian |
|
|
44 |
3 |
p. 349-350 |
artikel |
5 |
Donor age and ischemic time in heart transplantation – implications for organ preservation
|
Jernryd, Victoria |
|
|
44 |
3 |
p. 364-375 |
artikel |
6 |
Editorial Board
|
|
|
|
44 |
3 |
p. A3 |
artikel |
7 |
Factors associated with waitlist clinical deterioration among United States lung transplant recipients under the continuous distribution system
|
Mupfudze, Tatenda G. |
|
|
44 |
3 |
p. 412-421 |
artikel |
8 |
Harnessing Mesenchymal Stem Cells for Improving Lung Transplant Outcomes
|
Hassan, Ghandi F. |
|
|
44 |
3 |
p. 474-475 |
artikel |
9 |
Identification and validation of a threshold for early posttransplant bronchoalveolar fluid hyaluronan that distinguishes lung recipients at risk for chronic lung allograft dysfunction
|
Todd, Jamie L. |
|
|
44 |
3 |
p. 320-328 |
artikel |
10 |
Impact of tacrolimus vs cyclosporine on chronic lung allograft dysfunction incidence and allograft survival in the International Society of Heart and Lung Transplantation registry
|
Combs, Michael P. |
|
|
44 |
3 |
p. 307-317 |
artikel |
11 |
Information for Readers
|
|
|
|
44 |
3 |
p. A4 |
artikel |
12 |
Long short-term memory algorithm for personalized tacrolimus dosing: A simple and effective time series forecasting approach post-lung transplantation
|
Choshi, Haruki |
|
|
44 |
3 |
p. 351-361 |
artikel |
13 |
Lung allograft dysbiosis associates with immune response and primary graft dysfunction
|
Nelson, Nathaniel C. |
|
|
44 |
3 |
p. 422-434 |
artikel |
14 |
Measuring the seemingly unmeasurable: New metrics in heart transplantation
|
Teuteberg, Jeffrey |
|
|
44 |
3 |
p. 401-403 |
artikel |
15 |
Navigating surgical risks: The impact of BMI outliers on pulmonary endarterectomy outcomes
|
Mercier, Olaf |
|
|
44 |
3 |
p. 472-473 |
artikel |
16 |
Optimized surveillance frequency for low bone mineral density (BMD) screening using dual-energy X-ray absorptiometry (DXA) in patients after lung transplant
|
Sebro, Ronnie |
|
|
44 |
3 |
p. 404-411 |
artikel |
17 |
Periodic administration of levosimendan as a bridge to transplant : Potiusque sero quam nunquam
|
Masarone, Daniele |
|
|
44 |
3 |
p. 469 |
artikel |
18 |
Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation
|
Stewart, Adam G. |
|
|
44 |
3 |
p. 435-436 |
artikel |
19 |
Promise of a new day – will EVLP fulfill its therapeutic potential?
|
Vuthaluru, Srineil |
|
|
44 |
3 |
p. 460-461 |
artikel |
20 |
Refining the gold standard: Volume calibration methods for right ventricular pressure-volume loops
|
Houston, Brian A. |
|
|
44 |
3 |
p. 336-338 |
artikel |
21 |
Table of Contents
|
|
|
|
44 |
3 |
p. A5-A7 |
artikel |
22 |
Tacrolimus, cyclosporine, and lung transplantation in the “real world”
|
Halloran, Kieran |
|
|
44 |
3 |
p. 318-319 |
artikel |
23 |
Ten-year report on the first patient with HeartMate 3 left ventricular assist device
|
Hanke, Jasmin S. |
|
|
44 |
3 |
p. 470-471 |
artikel |
24 |
The effect of rewarming ischemia on tissue transcriptome and metabolome signatures: A clinical observational study in lung transplantation
|
Van Slambrouck, Jan |
|
|
44 |
3 |
p. 437-447 |
artikel |
25 |
The transformation of transplant medicine with artificial intelligence-assisted tacrolimus dosing
|
Leard, Lorriana E. |
|
|
44 |
3 |
p. 362-363 |
artikel |
26 |
The waiting is the hardest part
|
Clerkin, Kevin J. |
|
|
44 |
3 |
p. 386-388 |
artikel |
27 |
Toward early prediction of chronic allograft dysfunction using molecular biomarkers
|
Bell, Peter T. |
|
|
44 |
3 |
p. 329-330 |
artikel |
28 |
Towards a nuanced understanding of donor risk
|
Wayda, Brian |
|
|
44 |
3 |
p. 376-377 |
artikel |
29 |
Volume calibration with cardiac MRI versus hypertonic saline for right ventricular pressure-volume loops with exercise: Impact on ventricular function and ventricular-vascular coupling
|
Raza, Farhan |
|
|
44 |
3 |
p. 331-335 |
artikel |
30 |
Waitlist mortality for patients with cardiac allograft vasculopathy under the 2018 OPTN donor heart allocation system
|
Kadosh, Bernard S. |
|
|
44 |
3 |
p. 378-385 |
artikel |
31 |
Xenotransplantation of mitochondria: A novel strategy to alleviate ischemia-reperfusion injury during ex vivo lung perfusion
|
Bechet, Nicholas B. |
|
|
44 |
3 |
p. 448-459 |
artikel |